Univariate | Multivariate | |||||||
---|---|---|---|---|---|---|---|---|
Total (n=142) | Hazard ratio | (95% CI) | P-value | Hazard ratio | (95% CI) | P-value | ||
Ki67-p53 | Low Ki67 LI and Negative p53 | 88 | 1 | 1 | ||||
High Ki67 LI and/or Positive p53 | 54 | 9.3 | 3.5-24.5 | < 0.0001 | 11.6 | 4.2-32.3 | < 0.0001 | |
FOXA1 | Low | 20 | 1 | |||||
High | 119 | 1.4 | 0.51-3.6 | 0.54 | ||||
GATA3 | Negative | 30 | 1 | |||||
Positive | 112 | 1.5 | 0.65-3.5 | 0.34 | ||||
Basal phenotype marker | Negative | 9 | 1 | |||||
(CK5/6, CK14, EGFR) | Positive | 133 | 1.0 | 0.24-4.3 | 0.98 | |||
P-cadherin | Low | 90 | 1 | |||||
High | 52 | 1.3 | 0.59-2.8 | 0.52 | ||||
Tumor size | <5.0 cm | 17 | 1 | 1 | ||||
≧5.0 cm | 122 | 4.9 | 2.1-11.4 | 0.0003 | 5.7 | 2.3-14.1 | 0.0002 | |
Lymph-node metastasis | (−) | 80 | 1 | |||||
(+) | 59 | 3.8 | 1.6-8.8 | 0.0020 | ||||
Nuclear grade | 1, 2 | 111 | 1 | |||||
3 | 31 | 4.2 | 1.9-9.0 | 0.0002 | ||||
Chemotherapy | No | 93 | 1 | 1 | ||||
Yes | 49 | 2.6 | 1.2-5.7 | 0.014 | 3.5 | 1.5-7.9 | 0.0028 |